NHS England

Showing 15 posts of 60 posts found.

Chemotherapy

A brighter future for the Cancer Drugs Fund?

January 14, 2016
Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Prostate Cancer UK

In November 2015, NICE and NHS England announced proposed changes to the operation of the Cancer Drugs Fund. This is …

nhs_england_and_nice_logos

NHS England and NICE announce plans for new Cancer Drugs Fund

November 19, 2015
Medical Communications, Research and Development Cancer Drugs Fund, NHS England, NICE

A 12-week consultation on draft proposals for a revamped Cancer Drugs Fund (CDF) has been launched by NHS England and NICE, …

NICE rejects Roche’s Kadcyla for NHS; price still too high

November 17, 2015
Manufacturing and Production, Sales and Marketing Cancer Drugs Fund, Kadcyla, NHS England, NICE, Roche

NICE has published final draft guidance on Roche’s Kadcyla as a breast cancer treatment, deciding that the drug’s price remains …

NHS England reinstates treatments to Cancer Drugs Fund

November 4, 2015
Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NHS England

Five treatments in seven indications have been reinstated to Cancer Drugs Fund, as a result of negotiations between pharma companies …

avastin_24

Cancer Drugs Fund ‘not sustainable in current form’

September 17, 2015
CDF, Cancer Drugs Fund, Department of Health, NHS England, National Audit Office, Public Accounts Committe, Roche, avastin

The Cancer Drugs Fund has improved access to treatments, although the UK still lags behind other countries despite its ‘unsustainable’ …

NHS sign

Companies braced for new round of cancer cuts

September 4, 2015
Medical Communications, Sales and Marketing CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, cuts

Several treatments that extend the lives of people with cancer are expected to be removed from the Cancer Drugs Fund …

Pfizer image

Pfizer offers to pay for UK Lyrica switches

August 13, 2015
Lyrica, NHS England, Pfizer, generics, neuropathic pain, patents, pregabalin

Pfizer is to pay the administrative costs of GPs to switch patients to Lyrica from generic versions of pregabalin, as …

NHS sign

Cancer Drugs Fund assessment to be handed over to NICE

July 22, 2015
Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …

AbbVie

NHS England approves AbbVie’s Duodopa for Parkinson’s disease

July 6, 2015
Sales and Marketing AbbVie, Duodopa, James Palmer, NHS England, PPRS, Parkinson's, Parkinson's disease, commissioning

AbbVie has been handed a boost by NHS England, who has approved the prescribing of its Parkinson’s disease treatment Duodopa …

NHS image

NHS is struggling to improve cancer care

March 16, 2015
Sales and Marketing CRUK, Cancer, Department of Health, NHS, NHS England, oncology

The Department of Health and NHS England are struggling with the demand required to improve its cancer services according to …

screen_shot_2015-01-26_at_07

Working Life: NHS England pharma officer Dr Bruce Warner

January 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS England, Working Life, bruce warner, pharma officer

 How did you find your way into your current role? I have had a very eclectic career for a pharmacist …

CDF chair: more treatment reviews to come

January 16, 2015
Sales and Marketing CDF, Cancer Drugs Fund, NHS, NHS England, NICE, peter clark

The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments …

Afinitor image

Exclusive: Novartis drug struck off cancer drugs fund

January 8, 2015
Sales and Marketing Afinitor, Jevtana, NHS, NHS England, NICE, Novartis, Sanofi, everolimus

Novartis’ Afinitor (everolimus) will be removed from the Cancer Drugs Fund list when NHS England announces which drugs it can …

prof_tony_young

Innovation director appointed to NHS England

October 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS England, tony young

NHS England has hired a new national clinical director for innovation in Professor Tony Young. Young’s role will be to …

Sovaldi pack shot

Sovaldi ‘unaffordable’ says NHS documents

October 7, 2014
Medical Communications, Research and Development, Sales and Marketing NHS England, fund, hep C, sovaldi

Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after …

The Gateway to Local Adoption Series

Latest content